Arcadia Pharmaceutical Stock Price

Listing Websites about Arcadia Pharmaceutical Stock Price

Filter Type:
Popular Searched

 › Myuhcmedicare.com hwp sign in

 › 2022 wellcare act mastery exam quizlet

 › Myuhcmedicare com hwp products catalog 2022

 › Medicines and healthcare products regulatory

 › Myuhcmedicare hwp catalog online

 › United healthcare otc order online

 › New bedford ma board of health

 › Griffin hospital ct medical records

 › West ward pharmaceuticals stock

 › Aetna medicaid drug formulary 2022

Recently Searched

 › Arcadia pharmaceutical stock price

 › Approved medical abbreviations jcaho 2020

 › Usps drug testing policy

 › Drug test for truck drivers

 › Cdl license drug testing requirements

 › Does medicare pay for an annual physical

 › Valley medical center kent wa

 › Pharmacy assistant course online

 › Cdl positive drug test

 › Drug program for truckers

FAQ about Arcadia Pharmaceutical Stock Price

Who owns Acadia Pharmaceuticals stock?

Company insiders that own ACADIA Pharmaceuticals stock include Austin D Kim, Austin D Kim, Bros Advisors Lp Baker, Elena Ridloff, James M Daly, Laura Brege, Michael J Yang, Srdjan R Stankovic, Srdjan R Stankovic and Stephen Davis. View institutional ownership trends for ACADIA Pharmaceuticals.

How much is a share of Acadia worth?

One share of ACAD stock can currently be purchased for approximately $22.26. How much money does ACADIA Pharmaceuticals make? ACADIA Pharmaceuticals has a market capitalization of $3.58 billion and generates $441.76 million in revenue each year.

What are analysts'price targets for Acadia Pharmaceuticals (Acadia)?

19 Wall Street analysts have issued 12-month price objectives for ACADIA Pharmaceuticals' shares. Their forecasts range from $18.00 to $57.00. On average, they expect ACADIA Pharmaceuticals' stock price to reach $28.60 in the next twelve months. This suggests a possible upside of 28.5% from the stock's current price.

How did Acadia’s (ACAD) stock perform in after-hours trading?

Resultantly, its shares rise in after-hours trading. Acadia (ACAD) delivered earnings and revenue surprises of 66.67% and 3.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?